Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Antimicrobial Hydrogels Dissolve and Sterilize Drug-Resistant Biofilms

By LabMedica International staff writers
Posted on 04 Feb 2013
Synthetic antimicrobial hydrogels have been developed that demonstrate 100% efficiency in destruction of biofilms, with application potential for catheter and medical device coatings, implants, skin, and everyday surfaces.

Bacterial biofilms, which are adhesive groupings of pathogenic cells present in 80% of all infections, develop on the skin and on medical devices and household surfaces where they are difficult to treat and demonstrate high resistance to antibiotics. More...


In the current study, which was published in the January 7, 2013, issue of the journal, Angewandte Chemie, investigators at IBM (San Jose, CA, USA) and the Institute of Bioengineering and Nanotechnology (Singapore) described the development of biodegradable and injectable/moldable hydrogels with hierarchical nanostructures. These 90% aqueous hydrogels were made from specifically designed macromolecules containing a large number of atoms, which combined water solubility, positive charge, and biodegradability characteristics. When mixed with water and warmed to body temperature the polymers self-assembled, swelling into a synthetic gel that was easy to manipulate.

The hydrogels were shown to possess broad-spectrum antimicrobial activities and biofilm-disruption capability. Furthermore, they demonstrated no cytotoxicity in vitro, and displayed excellent skin biocompatibility in animals.

"This is a fundamentally different approach to fighting drug-resistant biofilms. When compared to capabilities of modern-day antibiotics and hydrogels, this new technology carries immense potential,” said Dr. James Hedrick, advanced organic materials scientist at IBM. “This new technology is appearing at a crucial time as traditional chemical and biological techniques for dealing with drug-resistant bacteria and infectious diseases are increasingly problematic.”

“We were driven to develop a more effective therapy against super bugs due to the lethal threat of infection by these rapidly mutating microbes and the lack of novel antimicrobial drugs to fight them. Using the inexpensive and versatile polymer materials that we have developed jointly with IBM, we can now launch a nimble, multipronged attack on drug-resistant biofilms which would help to improve medical and health outcomes,” said Dr. Yi-Yan Yang, group leader at the Institute of Bioengineering and Nanotechnology.

Related Links:
IBM
Institute of Bioengineering and Nanotechnology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.